Mcrae Capital Management Inc. Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mcrae Capital Management Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,765 shares of the medical equipment provider’s stock after selling 200 shares during the period. Mcrae Capital Management Inc.’s holdings in Intuitive Surgical were worth $1,850,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC increased its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Delos Wealth Advisors LLC increased its holdings in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the transaction, the director now owns 12,275 shares in the company, valued at $5,441,507.50. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 52,192 shares of company stock worth $25,398,571. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.1 %

ISRG stock opened at $511.27 on Friday. The stock has a market cap of $182.10 billion, a PE ratio of 82.20, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39. The firm’s 50-day simple moving average is $487.98 and its 200 day simple moving average is $442.67. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $523.34.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Citigroup lifted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, BTIG Research set a $535.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.